NCT06445296

Brief Summary

Shifting away from diets high in animal products towards more plant predominant diets is recommended by many health organizations to both reduce the negative environmental impacts of animal agriculture and to improve health outcomes. As a result, a number of plant-based meat alternatives such as Beyond Meat have been formulated to promote increased plant consumption. However, evidence is limited on the impact of newer plant-based meat alternatives on common cardiometabolic risk factors. The investigators aim to compare the acute metabolic, gastrointestinal, and inflammatory effects of a plant-based meat alternative (i.e., Beyond Meat) versus a comparable beef product within the context of high-fat, "Western-style" meal (i.e., eggs, meat, refined bread product). The investigators will also examine whether these responses differ based on whether individuals have a normal-weight or have overweight/obesity.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 26, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 6, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

June 6, 2024

Status Verified

May 1, 2024

Enrollment Period

9 months

First QC Date

April 26, 2024

Last Update Submit

May 31, 2024

Conditions

Keywords

Plant-based meat alternatives

Outcome Measures

Primary Outcomes (5)

  • Serum interleukin (IL)-6

    The investigators will measure serum IL-6 at baseline and 1-, 2-, 3-, and 4-hours after each meal containing either beef or Beyond Meat. Serum will be banked from each visit and this measurement will take place upon study completion.

    Through study completion, up to 1 year.

  • Serum lipopolysaccharide binding protein (LBP)

    The investigators will measure serum LBP at baseline and 1-, 2-, 3-, and 4-hours after each meal containing either beef or Beyond Meat. Serum will be banked from each visit and this measurement will take place upon study completion.

    Through study completion, up to 1 year.

  • Serum soluble CD14 (sCD14)

    The investigators will measure serum sCD14 at baseline and 1-, 2-, 3-, and 4-hours after each meal containing either beef or Beyond Meat. Serum will be banked from each visit and this measurement will take place upon study completion.

    Through study completion, up to 1 year.

  • Serum lipopolysaccharide

    The investigators will measure serum lipopolysaccharide at baseline and 1-, 2-, 3-, and 4-hours after each meal containing either beef or Beyond Meat. Serum will be banked from each visit and this measurement will take place upon study completion.

    Through study completion, up to 1 year.

  • Serum tumor necrosis factor (TNF)-alpha

    The investigators will measure serum (TNF)-alpha at baseline and 1-, 2-, 3-, and 4-hours after each meal containing either beef or Beyond Meat. Serum will be banked from each visit and this measurement will take place upon study completion.

    Through study completion, up to 1 year.

Secondary Outcomes (3)

  • Triglycerides

    Through study completion, up to 1 year.

  • HDL-C

    Through study completion, up to 1 year.

  • Glucose

    Through study completion, up to 1 year.

Other Outcomes (2)

  • Body composition

    Through study completion, up to 1 year.

  • Systolic and diastolic pressure

    Through study completion, up to 1 year.

Study Arms (2)

Meal Consumption with Beyond Meat

EXPERIMENTAL

During the Beyond Meat arm, participants will consume a high-fat meal containing Beyond Meat (rather than beef). Meals will be otherwise identical.

Other: High-fat meal containing Beyond Meat

Meal Consumption with Beef

ACTIVE COMPARATOR

During the Beef arm, participants will consume a high-fat meal containing beef (rather than Beyond Meat). Meals will be otherwise identical.

Other: High-fat meal containing beef

Interventions

High-fat meal (eggs cooked in butter, croissant) with 80% ground beef.

Meal Consumption with Beef

High-fat meal (eggs cooked in butter, croissant) with Beyond Meat Cookout Classic.

Meal Consumption with Beyond Meat

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years.
  • Body mass index \> 18.5 kg/m2
  • Not pregnant (females only)
  • Not postmenopausal (females only).
  • Not been diagnosed with cardiovascular disease.
  • Not been diagnosed with a cardiometabolic conditions (e.g., type 2 diabetes)
  • Not been diagnosed with a chronic inflammatory condition (e.g., rheumatoid arthritis, inflammatory bowel disease).
  • Does not regularly take anti-inflammatory drugs (more than 2x week).
  • Does not use glucose-lowering drugs (e.g., metformin)
  • Does not use lipid-lowering drugs (e.g., statins)
  • Does not use tobacco products or any illicit drugs.
  • Does not have a pacemaker.
  • Can consume pea products (Beyond Meat is made from pea protein).

You may not qualify if:

  • Not between the ages of 18-50
  • Body mass index \< 18.5 kg/m2
  • Pregnant (females only)
  • Postmenopausal status (females only).
  • Been diagnosed with cardiovascular disease.
  • Been diagnosed with a cardiometabolic conditions (e.g., type 2 diabetes)
  • Been diagnosed with a chronic inflammatory condition (e.g., rheumatoid arthritis, inflammatory bowel disease).
  • Regularly take anti-inflammatory drugs (more than 2x week).
  • Uses glucose-lowering drugs (e.g., metformin)
  • Uses lipid-lowering drugs (e.g., statins)
  • Uses tobacco products or any illicit drugs.
  • Have a pacemaker.
  • Allergic to pea products (Beyond Meat is made from pea protein).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Professions Building, Ball State University

Muncie, Indiana, 47306, United States

RECRUITING

Related Publications (1)

  • Fruit S, Keirns N, Higgins M, Quirk A, Schifferer J, Romanovich O, Yakos A, Osborne K, Trappe S, Keirns BH. Acute effects of a reformulated plant-based meat alternative compared to beef within a high-fat meal on inflammatory and metabolic factors: a randomized crossover trial. Appl Physiol Nutr Metab. 2025 Jan 1;50:1-11. doi: 10.1139/apnm-2024-0498.

MeSH Terms

Conditions

OverweightObesity

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Bryant Keirns

    Ball State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Bryant Keirns, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
While complete blinding is not possible (participants will see/taste the food they eat), the investigators will not tell participants whether they are consuming beef or Beyond Meat.
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2024

First Posted

June 6, 2024

Study Start

November 1, 2023

Primary Completion

August 1, 2024

Study Completion

December 1, 2024

Last Updated

June 6, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations